Sign In
21 Nov 2012 07:00
RNS Number : 6362R
Silence Therapeutics PLC
21 November 2012
Proposed Placing
London, 21 November, 2012 - Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), announces that the Company is in advanced discussions to raise additional funds from a strategic partner and existing shareholders through the issue of new ordinary shares.
The proposed issue of new ordinary shares is not expected to require shareholder approval.
Further details will be announced in due course.
-Ends-
Silence Therapeutics Ali Mortazavi (+44 7768 694739 /Tim Freeborn (+44 20 7491 6520) Email: a.mortazavi@silence-therapeutics.com t.freeborn@silence-therapeutics.com
| N+1 Singer Shaun Dobson/Jennifer Wyllie +44 20 7496 3000 shaun.dobson@n1singer.com jenny.wyllie@n1singer.com
|
This information is provided by RNS
The company news service from the London Stock Exchange
SLN.L (SLN)
Follow the stocks
